Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page
Users Online:292
Year : 2020  |  Volume : 8  |  Issue : 3  |  Page : 151-153

CytoSorb in the management of severe septic shock after coronary artery bypass graft surgery

1 Department of Cardiac Anaesthesia, Fortis Hospital, New Delhi, India
2 Department of Cardiothoracic and Vascular Surgery, Fortis Hospital, New Delhi, India

Correspondence Address:
Dr. Amit Prakash
Fortis Hospital, A-Block, Shalimar Bagh, New Delhi - 110 088
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/heartindia.heartindia_45_19

Rights and Permissions

Achieving sufficient adsorption of increased immune mediators with the help of hemadsorption has been a breakthrough discovery in the field of cardiac sciences. Any surgery, injury, or trauma causes the release of pro-inflammatory mediators, which may trigger a severe systemic inflammatory response syndrome (SIRS) and multiorgan failure. Septic shock after major cardiac surgeries is a feared complication, which increases mortality and morbidity and contributes to prolonged hospitalization. CytoSorb has been widely used worldwide in patients with septic shock as well as in postsurgery SIRS. This is a case of acute septic shock that developed after coronary artery bypass graft and which was efficiently managed using CytoSorb hemoadsorber.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded27    
    Comments [Add]    

Recommend this journal